Medical device-maker Senseonics (NYSE:SENS) has had an incredible run at the stock market this year. SENS stock has benefited from several catalysts, including the interest of the Reddit community. Source: Andrew_Popov / Shutterstock.com As a result, the stock is up a massive 330% this year. Moreover, its revenue growth has been impressive, and the company has…

At a short interest of over 30%, Senseonics Holdings (NYSE:SENS) enjoyed a short-squeeze rally in early June. Since then, volume dried up. SENS stock does not have any positive catalysts on the way to send the stock flying higher again. Source: Andrew_Popov / Shutterstock.com Without any directions to move the stock, why should shareholders continue…

Back in May, I wrote that Senseonics (NYSEAMERICAN:SENS) stock was likely to rise from $1.80 to over $3.00 per share. Now this has happened; on Aug. 9, SENS stock closed at $3.25 per share. Yet, it still looks like a good buy from here. Source: Minerva Studio / Shutterstock.com Why? Well, for the past three…

Senseonics Holdings (NYSE:SENS) is a medical technology company. It’s core business involves the design and development of an advanced glucose monitoring system for people to help manage diabetes. Source: Minerva Studio / Shutterstock.com The company’s key product line is the Eversense system which, according to the company,  “…in addition to featuring the first long-term and…

While Senseonics (NYSE:SENS) stock has a great deal of potential, the shares currently have a fairly high valuation. Source: Minerva Studio / Shutterstock.com Moreover, in the short-term and medium-term, SENS stock looks poised to fall significantly. Senseonics has developed Eversense, a 90-day continuous glucose monitoring (CGM) system. According to the company, the device provides continuous…